XML 21 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 129,452us-gaap_CashAndCashEquivalentsAtCarryingValue $ 12,365us-gaap_CashAndCashEquivalentsAtCarryingValue
Restricted cash 25,000us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue 25,000us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue
Short-term investments 171,353us-gaap_AvailableForSaleSecuritiesCurrent 225,459us-gaap_AvailableForSaleSecuritiesCurrent
Accounts receivable, net 2,885us-gaap_AccountsReceivableNetCurrent 3,607us-gaap_AccountsReceivableNetCurrent
Inventory 12,511us-gaap_InventoryNet 12,952us-gaap_InventoryNet
Other current assets 6,092us-gaap_OtherAssetsCurrent 8,817us-gaap_OtherAssetsCurrent
Total current assets 347,293us-gaap_AssetsCurrent 288,200us-gaap_AssetsCurrent
Property, plant and equipment, net 69,267us-gaap_PropertyPlantAndEquipmentNet 70,368us-gaap_PropertyPlantAndEquipmentNet
Goodwill 76,501us-gaap_Goodwill 76,501us-gaap_Goodwill
Other assets 6,151us-gaap_OtherAssetsNoncurrent 6,552us-gaap_OtherAssetsNoncurrent
Total assets 499,212us-gaap_Assets 441,621us-gaap_Assets
Current liabilities:    
Accounts payable 5,024us-gaap_AccountsPayableCurrent 2,703us-gaap_AccountsPayableCurrent
Accrued compensation 9,356us-gaap_EmployeeRelatedLiabilitiesCurrent 5,749us-gaap_EmployeeRelatedLiabilitiesCurrent
Accrued expenses 8,245us-gaap_AccruedLiabilitiesCurrent 6,418us-gaap_AccruedLiabilitiesCurrent
Accrued clinical trial expenses 8,747nktr_AccruedClinicalTrialExpenses 7,708nktr_AccruedClinicalTrialExpenses
Interest payable 3,167us-gaap_InterestPayableCurrent 6,917us-gaap_InterestPayableCurrent
Capital lease obligations, current portion 5,412us-gaap_CapitalLeaseObligationsCurrent 4,512us-gaap_CapitalLeaseObligationsCurrent
Deferred revenue, current portion 24,959us-gaap_DeferredRevenueCurrent 24,473us-gaap_DeferredRevenueCurrent
Other current liabilities 10,534us-gaap_OtherLiabilitiesCurrent 5,567us-gaap_OtherLiabilitiesCurrent
Total current liabilities 75,444us-gaap_LiabilitiesCurrent 64,047us-gaap_LiabilitiesCurrent
Senior secured notes 125,000us-gaap_SeniorLongTermNotes 125,000us-gaap_SeniorLongTermNotes
Capital lease obligations, less current portion 4,386us-gaap_CapitalLeaseObligationsNoncurrent 4,139us-gaap_CapitalLeaseObligationsNoncurrent
Liability related to sale of future royalties 121,558nktr_LiabilityRelatedToSaleOfPotentialFutureRoyaltiesNonCurrent 120,471nktr_LiabilityRelatedToSaleOfPotentialFutureRoyaltiesNonCurrent
Deferred revenue, less current portion 78,418us-gaap_DeferredRevenueNoncurrent 76,911us-gaap_DeferredRevenueNoncurrent
Other long-term liabilities 17,101us-gaap_OtherLiabilitiesNoncurrent 14,721us-gaap_OtherLiabilitiesNoncurrent
Total liabilities 421,907us-gaap_Liabilities 405,289us-gaap_Liabilities
Commitments and contingencies      
Stockholders' equity:    
Preferred stock, $0.0001 par value, 10,000 shares authorized, no shares designated, issued or outstanding at March 31, 2015 or December 31, 2014, respectively 0us-gaap_PreferredStockValue 0us-gaap_PreferredStockValue
Common stock, $0.0001 par value, 300,000 authorized, 131,451 shares and 131,216 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively 13us-gaap_CommonStockValue 13us-gaap_CommonStockValue
Capital in excess of par value 1,831,057us-gaap_AdditionalPaidInCapitalCommonStock 1,824,195us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated other comprehensive loss (1,276)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax (1,567)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Accumulated deficit (1,752,489)us-gaap_RetainedEarningsAccumulatedDeficit (1,786,309)us-gaap_RetainedEarningsAccumulatedDeficit
Total stockholders' equity 77,305us-gaap_StockholdersEquity 36,332us-gaap_StockholdersEquity
Total liabilities and stockholders' equity $ 499,212us-gaap_LiabilitiesAndStockholdersEquity $ 441,621us-gaap_LiabilitiesAndStockholdersEquity